Role of the Leukotriene B4 Receptors in Asthma
白三烯 B4 受体在哮喘中的作用
基本信息
- 批准号:6511639
- 负责人:
- 金额:$ 5.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-01 至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by the applicant): Asthma is now recognized as an
inflammatory disease of the airways. Eosinophils, neutrophils, macrophages and
lymphocytes, are also recruited into the airways. The arachidonic acid
derivative leukotriene B4 (LTB4) and its receptors are important mediators of
leukocyte chemotaxis. LTB4 signaling has been implicated in the pathogenesis of
asthma and in a murine model of this disorder. However, the precise role of the
LTB4 receptors, BLTR1 and BLTR2, in the pathobiology of asthma is incompletely
known. Our laboratory has recently generated a mouse strain with a targeted
deletion in the gene that codes for BLTR1 (BLTR1-/-). Preliminary experiments
using this mouse strain in a murine model of asthma have shown a reduction in
eosinophils recruited into the airways. Our hypothesis is that LTB4 is an
important chemoattractant for leukocytes in this model of asthma and that its
actions are mediated primarily through the BLTR1 receptor. We also propose that
LTB4 signaling is important in the development of airway remodeling.
Specifically we seek to determine the following: 1) if BLTR1 signaling is
important for the recruitment of eosinophils, neutrophils, and macrophages in
this model of asthma; 2) if BLTR1 effects the recruitment and profile of T
lymphocytes in the airways and lymph nodes in this model; 3) if BLTR1 signaling
is important in airways hyperreactivity and mucous production; 4) if BLTR1
signaling effects airway remodeling in a chronic asthma model; 5) if the newly
described receptor BLTR2 has any functional role in this murine model of
asthma. Using a model of asthma in BLTR1-/- mice we hope to precisely define
the role of BLTR1 in asthma pathogenesis. Repeat experiments in the presence of
a BLTR2 antagonist will also allow characterization of the role of this
receptor in asthma.
描述(由申请人提供):哮喘现在被认为是一种
呼吸道炎症性疾病。嗜酸性粒细胞、中性粒细胞、巨噬细胞和
淋巴细胞也被募集到气道中。花生四烯酸
衍生物白三烯B4(LTB 4)及其受体是重要的介导剂,
白细胞趋化性LTB 4信号转导与肺结核的发病机制有关,
哮喘和这种疾病的小鼠模型。然而,
LTB 4受体,BLTR 1和BLTR 2,在哮喘的病理生物学是不完全的
知道的我们的实验室最近培育了一种小鼠品系,
编码BLTR 1的基因缺失(BLTR 1-/-)。初步实验
在哮喘的鼠模型中使用该小鼠品系显示出
嗜酸性粒细胞聚集到气道中。我们的假设是LTB 4是一种
哮喘模型中白细胞重要化学引诱物及其
作用主要通过BLTR 1受体介导。我们亦建议
LTB 4信号传导在气道重塑的发展中是重要的。
具体地,我们寻求确定以下内容:1)如果BLTR 1信号传导是
对嗜酸性粒细胞、中性粒细胞和巨噬细胞的募集很重要,
2)如果BLTR 1影响T细胞的募集和分布,
3)如果BLTR 1信号传导
在气道高反应性和粘液产生中是重要的; 4)如果BLTR 1
在慢性哮喘模型中信号传导影响气道重塑; 5)如果新的
所描述的受体BLTR 2在该鼠模型中具有任何功能作用,
哮喘使用BLTR 1-/-小鼠的哮喘模型,我们希望精确地定义
BLTR 1在哮喘发病机制中的作用。在存在以下物质的情况下重复实验
BLTR 2拮抗剂也将允许表征这种作用,
哮喘中的受体
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin David Medoff其他文献
Benjamin David Medoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benjamin David Medoff', 18)}}的其他基金
Trained Immunity in the Airway Mucosa Differentiates Asthma from Allergy Alone
气道粘膜经过训练的免疫力可将哮喘与单纯过敏区分开来
- 批准号:
10673238 - 财政年份:2023
- 资助金额:
$ 5.44万 - 项目类别:
Targeting durotaxis in lung injury and fibrosis
靶向肺损伤和纤维化中的杜罗轴
- 批准号:
10364927 - 财政年份:2021
- 资助金额:
$ 5.44万 - 项目类别:
Targeting durotaxis in lung injury and fibrosis
靶向肺损伤和纤维化中的杜罗轴
- 批准号:
10532249 - 财政年份:2021
- 资助金额:
$ 5.44万 - 项目类别:
Targeting the ADAM10-sEphrin-B2 pathway in pulmonary fibrosis
靶向 ADAM10-sEphrin-B2 通路治疗肺纤维化
- 批准号:
10599961 - 财政年份:2019
- 资助金额:
$ 5.44万 - 项目类别:
Targeting the ADAM10-sEphrin-B2 pathway in pulmonary fibrosis
靶向 ADAM10-sEphrin-B2 通路治疗肺纤维化
- 批准号:
10372067 - 财政年份:2019
- 资助金额:
$ 5.44万 - 项目类别:
相似海外基金
Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
- 批准号:
2901112 - 财政年份:2024
- 资助金额:
$ 5.44万 - 项目类别:
Studentship
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
- 批准号:
485322 - 财政年份:2023
- 资助金额:
$ 5.44万 - 项目类别:
Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
- 批准号:
493135 - 财政年份:2023
- 资助金额:
$ 5.44万 - 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
- 批准号:
493526 - 财政年份:2023
- 资助金额:
$ 5.44万 - 项目类别:
Operating Grants
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
- 批准号:
495593 - 财政年份:2023
- 资助金额:
$ 5.44万 - 项目类别:
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
- 批准号:
485504 - 财政年份:2023
- 资助金额:
$ 5.44万 - 项目类别:
Salary Programs
Mechanistic Study of Inspiratory Training in Childhood Asthma
儿童哮喘吸气训练机制研究
- 批准号:
10637048 - 财政年份:2023
- 资助金额:
$ 5.44万 - 项目类别:
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
- 批准号:
10678307 - 财政年份:2023
- 资助金额:
$ 5.44万 - 项目类别:
Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
- 批准号:
10664599 - 财政年份:2023
- 资助金额:
$ 5.44万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 5.44万 - 项目类别: